[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Zeliha Alicikus\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":108},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,65,84],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100621384","pediatric-pilonidal-sinus-surgical-treatment-100621384",false,"NCT07369921","Pediatric Pilonidal Sinus Surgical Treatment","Comparison of Four Different Surgical Methods for the Treatment of Sacrococcygeal Pilonidal Sinus: a Randomized Controlled Trial","Inclusion Criteria:\n\n* having sacrococcygeal pilonidal sinus disease\n* written informed (family) consent were eligible for inclusion in this trial\n\nExclusion Criteria:\n\n* Being over 18 years old or under 12 years old\n* recurrent sacrococcygeal pilonidal sinus disease","ALL","12 Years","18 Years",{"count":20,"type":21},80,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of study to evaluate four different treatment options for pilonidal sinus disease in a randomized controlled trial to find the most suitable treatment option.",[27,28,29],"Surgery","Pilonidal Sinus","Pediatric",[28,31],"pediatric surgery","RECRUITING","2026-04-11",{"date":35,"type":36},"2026-04-14","ACTUAL",{"date":38,"type":21},"2026-04-30",{"date":40,"type":21},"2026-05-30",{"name":42,"class":43},"Zeliha Alicikus","OTHER_GOV",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":59,"startDateStruct":60,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100615286","comparative-outcomes-of-pcc-and-recombinant-activated-factor-viia-in-trauma-associated-massive-transfusion-100615286","NCT07290634","Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion","Comparative Outcomes of Prothrombin Complex Concentrate and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion: A Retrospective Cohort Study","Inclusion Criteria:\n\n* Adults ≥18 years\n* Trauma patients directly admitted from the scene with highest-level trauma activation: Injury -Severity Score (ISS) \\>15.\n* Requirement for massive transfusion, defined as ≥3 units packed red blood cells (PRBC) within the first hour or ≥10 PRBC within the first 24 hours\n\nExclusion Criteria:\n\n* Traumatic cardiac injury\n* Death anticipated within the first hour of admission: ISS score \\>49\n* Pre-injury anticoagulant therapy\n* Known pregnancy\n* Pre-injury terminal illness",{"count":5,"type":21},"OBSERVATIONAL","This study aims to compare the incidence of thromboembolic complications among trauma patients receiving PCC, rFVIIa, both agents, or neither during massive transfusion. Secondary objectives include comparing mortality, transfusion requirements, intensive care unit (ICU) and hospital length of stay, ventilator-free days, and the incidence of transfusion-associated adverse events such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). Subgroup analyses will evaluate outcomes in patients with and without laboratory-confirmed TIC (INR \\>1.2).",[56,57,58],"Thromboembolus","Massive Blood Transfusion; Thrombocytopenia","Trauma",{"date":35,"type":36},{"date":38,"type":21},{"date":62,"type":21},"2026-06-30",{"name":42,"class":43},2,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":79,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":83,"locationsCount":4},"100615808","peri-intubation-adverse-airway-events-in-critically-ill-patients-with-morbid-and-super-obesity-100615808","NCT07297420","Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity","Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity: A Retrospective Analysis","Inclusion Criteria:\n\n* Age ≥ 18 years\n* BMI ≥40\n* Admission to the surgical ICU and intubated during ICU stay\n* Availability of complete clinical data\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* BMI\\\u003C40\n* No intubation\n* Incomplete or missing medical records",{"count":64,"type":21},"This study aims to compare the incidence and characteristics of peri-intubation adverse airway events in critically ill trauma patients with morbid obesity versus those with super obesity, and to determine whether increasing BMI independently predicts severe peri-intubation complications.",[75,76,77],"Obesity","Airway Complication of Anesthesia","Intubation; Difficult or Failed","NOT_YET_RECRUITING",{"date":35,"type":36},{"date":81,"type":21},"2026-04-23",{"date":62,"type":21},{"name":42,"class":43},{"id":85,"slug":86,"hasResults":11,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":4,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":91,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":92,"conditions":93,"keywords":100,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":102,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":44},"100610009","induction-agent-choice-with-early-mortality-and-prognostic-outcomes-in-critically-ill-patients-100610009","NCT07222007","Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients","Association of Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients: A Large-Scale Retrospective Cohort Analysis","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Admission to the surgical ICU for critical care\n* Administration of one of the studied induction agents\n* Availability of complete clinical data\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Absence of documented induction agent administration\n* Incomplete or missing medical records",{"count":5,"type":21},"The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.",[94,95,96,97,98,99],"Critically Ill","Intubation Complication","Oxygenation","Airway Management","Propofol","Ketamine",[101],"intubation, critically ill patients, airway management",{"date":35,"type":36},{"date":104,"type":21},"2026-04-18",{"date":106,"type":21},"2026-07-01",{"name":42,"class":43},""]